202 related articles for article (PubMed ID: 36656436)
1. Alternative splicing: a new breakthrough for understanding tumorigenesis and potential clinical applications.
Park J; Park J; Chung YJ
Genes Genomics; 2023 Apr; 45(4):393-400. PubMed ID: 36656436
[TBL] [Abstract][Full Text] [Related]
2. Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities.
Venkataramany AS; Schieffer KM; Lee K; Cottrell CE; Wang PY; Mardis ER; Cripe TP; Chandler DS
Ann Oncol; 2022 Jun; 33(6):578-592. PubMed ID: 35339647
[TBL] [Abstract][Full Text] [Related]
3. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of aberrant alternative splicing related to carcinogenesis and prognosis of papillary thyroid cancer.
Zheng X; Feng L; Yin Y; Yu C; He X; Zhu J; Zhang M; Yu J; Xu M
Aging (Albany NY); 2021 Oct; 13(19):23149-23168. PubMed ID: 34628367
[TBL] [Abstract][Full Text] [Related]
5. Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics.
Bessa C; Matos P; Jordan P; Gonçalves V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261131
[TBL] [Abstract][Full Text] [Related]
6. SERBP1 affects the apoptotic level by regulating the expression and alternative splicing of cellular and metabolic process genes in HeLa cells.
Zhou J; Chen W; He Q; Chen D; Li C; Jiang C; Ding Z; Qian Q
PeerJ; 2022; 10():e14084. PubMed ID: 36213507
[TBL] [Abstract][Full Text] [Related]
7. Identification of neoantigens derived from alternative splicing and RNA modification.
Park J; Chung YJ
Genomics Inform; 2019 Sep; 17(3):e23. PubMed ID: 31610619
[TBL] [Abstract][Full Text] [Related]
8. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
9. TranscriptAchilles: a genome-wide platform to predict isoform biomarkers of gene essentiality in cancer.
Carazo F; Campuzano L; Cendoya X; Planes FJ; Rubio A
Gigascience; 2019 Apr; 8(4):. PubMed ID: 30942869
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing enriched cDNA libraries identify breast cancer-associated transcripts.
Ferreira EN; Rangel MC; Galante PF; de Souza JE; Molina GC; de Souza SJ; Carraro DM
BMC Genomics; 2010 Dec; 11 Suppl 5(Suppl 5):S4. PubMed ID: 21210970
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
[TBL] [Abstract][Full Text] [Related]
12. Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities.
Robinson TJ; Freedman JA; Al Abo M; Deveaux AE; LaCroix B; Patierno BM; George DJ; Patierno SR
Clin Cancer Res; 2019 May; 25(10):2963-2968. PubMed ID: 30755441
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748
[TBL] [Abstract][Full Text] [Related]
14. Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response.
Lu J; Wei S; Lou J; Yin S; Zhou L; Zhang W; Zheng S
Med Sci Monit; 2020 Jul; 26():e925733. PubMed ID: 32706768
[TBL] [Abstract][Full Text] [Related]
15. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
16. Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy.
Mehterov N; Kazakova M; Sbirkov Y; Vladimirov B; Belev N; Yaneva G; Todorova K; Hayrabedyan S; Sarafian V
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356101
[TBL] [Abstract][Full Text] [Related]
17. Efficient and Accurate Quantitative Profiling of Alternative Splicing Patterns of Any Complexity on a Laptop.
Sterne-Weiler T; Weatheritt RJ; Best AJ; Ha KCH; Blencowe BJ
Mol Cell; 2018 Oct; 72(1):187-200.e6. PubMed ID: 30220560
[TBL] [Abstract][Full Text] [Related]
18.
Zhang Z; Zhou C; Tang L; Gong Y; Wei Z; Zhang G; Wang F; Liu Q; Yu J
Aging (Albany NY); 2020 Jul; 12(14):14633-14648. PubMed ID: 32697765
[TBL] [Abstract][Full Text] [Related]
19. AS-Quant: Detection and Visualization of Alternative Splicing Events with RNA-seq Data.
Fahmi NA; Nassereddeen H; Chang J; Park M; Yeh H; Sun J; Fan D; Yong J; Zhang W
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922891
[TBL] [Abstract][Full Text] [Related]
20. Comparative transcriptomics analysis uncovers alternative splicing events and molecular markers in cabbage (Brassica oleracea L.).
Xu Y; Zeng A; Song L; Li J; Yan J
Planta; 2019 May; 249(5):1599-1615. PubMed ID: 30771045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]